Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2.

scientific article published on 16 March 2010

Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10549-010-0828-9
P698PubMed publication ID20232140

P2093author name stringPaul S Rennie
Irvin S Y Chen
William Jia
Kai-xin Zhang
Connie Kim
Elaine Chow
P2860cites workCancer statistics, 2009Q29547625
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugateQ34880994
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)89-97
P577publication date2010-03-16
P1433published inBreast Cancer Research and TreatmentQ326085
P1476titleTargeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2.
P478volume125

Reverse relations

cites work (P2860)
Q41139635A lentiviral vector-based therapeutic vaccine encoding Ag85B-Rv3425 potently increases resistance to acute tuberculosis infection in mice
Q34757199DARPins: an efficient targeting domain for lentiviral vectors
Q36536212In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens
Q35638350The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors
Q57050793Versatile targeting system for lentiviral vectors involving biotinylated targeting molecules

Search more.